Verifying…
Automatisch übersetzt. Dosierung und Warnhinweise: bitte im englischen Original prüfen. Auf Englisch lesen
Home / Medicines A–Z / Minocycline

Minocycline

Minocycline is a brand of Minocycline.

ZILXI is indicated for the treatment of inflammatory lesions of rosacea in adults [see Clinical Studies ( 14 )] . Limitations of Use This formulation.

Checked against the official label · Updated

Prescription medicine Topical Safety alerts on record

Minocycline: quick answers

Used for
ZILXI is indicated for the treatment of inflammatory lesions of rosacea in adults [see Clinical Studies ( 14 )] .
Children
The safety and effectiveness of ZILXI for the treatment of inflammatory lesions of rosacea have not been evaluated in pediatric patients.
Prescription
Prescription medicine in the United States; rules differ by country.

From the official label (Feb 2024). Your prescription and pharmacist come first.

How to use Minocycline

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

ZILXI is indicated for the treatment of inflammatory lesions of rosacea in adults [see Clinical Studies ( 14 )] . Limitations of Use This formulation of minocycline has not been evaluated in the treatment of infections. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, ZILXI should be used only as indicated [see Warnings and Precautions ( 5.14 )] . ZILXI is a tetracycline-class drug indicated for the treatment of inflammatory lesions of rosacea in adults. ( 1 ) Limitations of Use This formulation of minocycline has not been evaluated in the treatment of infections. …

How to take it and how often
  • For topical use only, not for oral, ophthalmic or intravaginal use
  • After shaking the can well, a small amount of topical foam (e.g. a cherry-sized amount) should be expressed from the can onto the fingertips of the hand and then applied as a thin layer over all areas of the face
  • Additional ZILXI foam may be used as needed to ensure the entire face is treated
  • The topical foam should be applied at approximately the same time each day at least 1 hour before bedtime
  • The patient should not bathe, shower or swim for at least 1 hour after application of the product
  • Apply ZILXI over all areas of the face once daily
  • ZILXI should be gently rubbed into the skin
Strengths it comes in

Topical foam, 1.5%. Each gram of ZILXI contains 15 mg of minocycline equivalent to 16 mg of minocycline hydrochloride and is supplied as a yellow suspension in a pressurized aluminum aerosol container (can). Foam, 1.5%. ( 3 )

Children
  • The safety and effectiveness of ZILXI
  • For the treatment of inflammatory lesions of rosacea have not been evaluated
  • In pediatric patients
Older adults

There were 278 subjects aged 65 or older in the clinical trials of ZILXI (16.6% of 1,678 subjects). No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.

While you are taking it
  • Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use)
  • Inform patients using ZILXI (minocycline) topical foam, 1.5% of the following information and instructions: Flammability The propellant in ZILXI is flammable
  • Instruct the patient to avoid fire, flame, and smoking during and immediately following application
  • Tooth Discoloration Advise caregivers of pediatric patients that ZILXI may cause permanent discoloration of deciduous and permanent teeth during tooth development (generally up to the age of 8 years) based on observations with oral tetracycline
  • Lactation Advise women that breastfeeding is not recommended during ZILXI therapy. …
Talk to a doctor first if
  • This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines or any other ingredients in ZILXI
  • This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines or any of the ingredients in ZILXI
Medicines it may not mix with

• Patients on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. ( 7.1 ) • Penicillin: avoid coadministration. ( 7.2 ) 7.1 Anticoagulants Because tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. 7.2 Penicillin Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline-class drugs in conjunction with penicillin. 7.3 Drug/Laboratory Test Interactions False elevations of urinary catecholamine levels may occur due to interference with the fluorescence test.

Warnings

• The propellant in ZILXI is flammable. Instruct the patient to avoid fire, flame, and smoking during and immediately following application. ( 5.1 ) • The use of tetracycline-class of drugs orally during the second and third trimesters of pregnancy, infancy and childhood up to the age of 8 years may cause permanent discoloration of the teeth (yellow-gray-brown) and reversible inhibition of bone growth. ( 5.2 , 5.3 , 5.4 , 8.4 ) • If Clostridioides difficile associated diarrhea occurs, discontinue ZILXI. ( 5.5 ) • If liver injury is suspected, discontinue ZILXI. …

Possible side effects

The most commonly observed adverse reaction (incidence ≥1%) is diarrhea. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Journey Medical Corporation at 1-855-531-1859 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. In three (two Phase 3 and one Phase 2) multicenter, randomized, double-blind, vehicle-controlled trials, adult subjects applied ZILXI or vehicle once daily for 12 weeks. …

Pregnancy and breastfeeding

8.1 Pregnancy Risk Summary Available data with ZILXI use in pregnant women are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. Systemic absorption of ZILXI in humans is low following once daily topical administration of ZILXI under maximal clinical use conditions [see Clinical Pharmacology ( 12.3 )] . …

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2024-02-09.

How much Minocycline costs

In other countries

Prices in other countries are not what you will pay where you live; they show how prices compare.

What Minocycline looks like

Compare with your pack. Packs differ between countries and makers; a pack that looks different is not always fake, so scan it to check the registration.

Same medicine, other brands

Products with Minocycline as the active ingredient. Names differ between countries.

Registered products

United States (FDA)

EmrosiMINOCYCLINE HYDROCHLORIDE 40 mg/1 · Capsule · Journey Medical Corporation
NDC 69489-131Label
Minocycline HydrochlorideMINOCYCLINE HYDROCHLORIDE 55 mg/1 · Tablet, Extended Release · Zydus Pharmaceuticals (USA) Inc.
NDC 68382-550Label
Minocycline HydrochlorideMINOCYCLINE HYDROCHLORIDE 80 mg/1 · Tablet, Extended Release · Zydus Pharmaceuticals (USA) Inc.
NDC 68382-551Label
Minocycline HydrochlorideMINOCYCLINE HYDROCHLORIDE 105 mg/1 · Tablet, Extended Release · Zydus Pharmaceuticals (USA) Inc.
NDC 68382-552Label
Minocycline HydrochlorideMINOCYCLINE HYDROCHLORIDE 100 mg/1 · Capsule · Advanced Rx Pharmacy of Tennessee, LLC
NDC 80425-0390Label

Other countries: check your pack's registration number and we point you to your regulator.

Safety alerts and recalls

Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLCU.S. FDA Class II
1 Jun 2026 · Ascend Laboratories, LLC · OngoingFailed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited, INDIA, Manufactured for: EPI Health, LLC, ChU.S. FDA Class II
23 Apr 2024 · EPI Health, LLC · TerminatedCGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
minolira (minocycline hydrochloride) extended-release tablets, 105mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited, INDIA, Manufactured for: EPI Health, LLC, ChU.S. FDA Class II
23 Apr 2024 · EPI Health, LLC · TerminatedCGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: AscendU.S. FDA Class III
22 Jan 2020 · Ascend Laboratories LLC · TerminatedFailed Dissolution Specifications: low out of specification results for dissolution testing.

A recall usually affects certain batches only. Compare the lot number on your pack.

Check your pack of Minocycline

Type the registration number on the pack, or scan it with your camera.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

Questions about Minocycline

What is in Minocycline?

Minocycline contains Minocycline. Other brands with the same active ingredient work the same way; the dose and strength on your pack are what matter.

What is Minocycline used for?

ZILXI is indicated for the treatment of inflammatory lesions of rosacea in adults [see Clinical Studies ( 14 )] . Limitations of Use This formulation of minocycline has not been evaluated in the treatment of infections. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, ZILXI should be used only as indicated [see Warnings and Precautions ( 5.14 (From the official U.S. FDA label.)

How do I take Minocycline?

Follow your prescription or the leaflet in your pack. The official label says: For topical use only, not for oral, ophthalmic or intravaginal use. After shaking the can well, a small amount of topical foam (e.g. a cherry-sized amount) should be expressed from the can onto the fingertips of the hand and then applied as a thin layer over all areas of the face. Additional ZILXI foam may be used as needed to ensure the entire face is treated. The topical foam…

Can I take Minocycline while breastfeeding?

Lactation Advise women that breastfeeding is not recommended during ZILXI therapy. Ask your doctor or midwife first.

Do I need a prescription for Minocycline?

Usually yes. Minocycline is a prescription medicine in most countries. Rules differ by country.

What brands contain Minocycline?

Minocycline is sold under names such as Ximino, Minocin, Minolira, Amzeeq, Zilxi, Emrosi, Arestin, Solodyn. Brand names differ between countries.

What are the side effects of Minocycline?

The official label lists: The most commonly observed adverse reaction (incidence ≥1%) is diarrhea. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Journey Medical Corporation at 1-855-531-1859 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trial… Tell your doctor about any side effect that bothers you or does not go away.

Can children take Minocycline?

The safety and effectiveness of ZILXI for the treatment of inflammatory lesions of rosacea have not been evaluated in pediatric patients. Always use the dose for the child's age or weight on the pack or prescription.

Can I take Minocycline when pregnant or breastfeeding?

8.1 Pregnancy Risk Summary Available data with ZILXI use in pregnant women are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. Systemic absorption of ZILXI in humans is low following once daily topical administration of ZILXI under maximal clinical use conditions [see Clinical Pharmacology ( 12… Ask your doctor or midwife first.

What medicines interact with Minocycline?

• Patients on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. ( 7.1 ) • Penicillin: avoid coadministration. ( 7.2 ) 7.1 Anticoagulants Because tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. 7.2 Penicillin Since bact… Use the free interaction checker before combining medicines.

How can I check that my Minocycline is genuine?

Scan the registration number on your pack with PillVera (NAFDAC number in Nigeria, NDC in the United States, DIN in Canada), check the expiry date and buy only from licensed pharmacies.

Sources

This page shows what official sources say, in plain words. It is not medical advice: your prescription and your doctor or pharmacist come first. Brand names, strengths and rules differ between countries.